about
Virus-receptor interactions of coxsackie B viruses and their putative influence on cardiotropismThe Novel Extracellular Cyclophilin A (CyPA) - Inhibitor MM284 Reduces Myocardial Inflammation and Remodeling in a Mouse Model of Troponin I -Induced MyocarditisCardiomyocyte-specific IκB kinase (IKK)/NF-κB activation induces reversible inflammatory cardiomyopathy and heart failure.Persistent troponin elevation in a patient with cardiac amyloidosis.Parvovirus B19-induced vascular damage in the heart is associated with elevated circulating endothelial microparticles.Protease-activated receptor-2 regulates the innate immune response to viral infection in a coxsackievirus B3-induced myocarditisImpairment of immunoproteasome function by β5i/LMP7 subunit deficiency results in severe enterovirus myocarditis.Virus-induced dilated cardiomyopathy is characterized by increased levels of fibrotic extracellular matrix proteins and reduced amounts of energy-producing enzymes.Mesenchymal stromal cells but not cardiac fibroblasts exert beneficial systemic immunomodulatory effects in experimental myocarditis.Selective regulation of cardiac organic cation transporter novel type 2 (OCTN2) in dilated cardiomyopathyOngoing coxsackievirus myocarditis is associated with increased formation and activity of myocardial immunoproteasomesClinical and histopathological features of patients with systemic sclerosis undergoing endomyocardial biopsyVariants of Toll-like receptor 4 predict cardiac recovery in patients with dilated cardiomyopathy.Comparison of Ventricular Inducibility with Late Gadolinium Enhancement and Myocardial Inflammation in Endomyocardial Biopsy in Patients with Dilated CardiomyopathyIn vivo T2* weighted MRI visualizes cardiac lesions in murine models of acute and chronic viral myocarditis.PA28 modulates antigen processing and viral replication during coxsackievirus B3 infection.Myocardial gene expression profiles and cardiodepressant autoantibodies predict response of patients with dilated cardiomyopathy to immunoadsorption therapyProteomic analyses of age related changes in A.BY/SnJ mouse hearts.Human herpesvirus 6 subtype A-associated myocarditis with 'apical ballooning'Cardiovascular magnetic resonance patterns of biopsy proven cardiac involvement in systemic sclerosis.Cardiovascular magnetic resonance risk stratification in patients with clinically suspected myocarditis.Imaging in inflammatory heart disease: from the past to current clinical practice.Molecular phenotypes of human parvovirus B19 in patients with myocarditis.Osteopontin: a biomarker to predict the outcome of inflammatory heart disease.Enforced viral replication activates adaptive immunity and is essential for the control of a cytopathic virus.Virus-host coevolution in a persistently coxsackievirus B3-infected cardiomyocyte cell line.Changes of myocardial gene expression and protein composition in patients with dilated cardiomyopathy after immunoadsorption with subsequent immunoglobulin substitution.A new monoclonal antibody (Cox mAB 31A2) detects VP1 protein of coxsackievirus B3 with high sensitivity and specificity.Predictors of outcome in patients with parvovirus B19 positive endomyocardial biopsy.State-of-the-art: Myokarditis – Klinik, Diagnose und therapeutische Optionen.The immunoproteasome controls the availability of the cardioprotective pattern recognition molecule Pentraxin3.Cardiac fibroblasts aggravate viral myocarditis: cell specific coxsackievirus B3 replication.Interleukin-6 receptor inhibition modulates the immune reaction and restores titin phosphorylation in experimental myocarditis.Endomyocardial expression of SDF-1 predicts mortality in patients with suspected myocarditis.Effective chemokine secretion by dendritic cells and expansion of cross-presenting CD4-/CD8+ dendritic cells define a protective phenotype in the mouse model of coxsackievirus myocarditis.Protective Function of STAT3 in CVB3-Induced Myocarditis.Disrupting the EMMPRIN (CD147)-cyclophilin A interaction reduces infarct size and preserves systolic function after myocardial ischemia and reperfusion.Sustained nitric oxide synthesis contributes to immunopathology in ongoing myocarditis attributable to interleukin-10 disorders.Ubiquitin-like protein ISG15 (interferon-stimulated gene of 15 kDa) in host defense against heart failure in a mouse model of virus-induced cardiomyopathy.Heme oxygenase-1 mediates oxidative stress and apoptosis in coxsackievirus B3-induced myocarditis.
P50
Q28202035-E07FA52A-E1B6-4BE7-B9B8-D8CCD3CD6F21Q30316634-7C99CD4C-5C85-42EC-9781-19005452ADE4Q30523246-ABE46C17-269E-4922-935B-2779E5444CEAQ33157918-8DFB8FBC-2689-4374-9468-71D1DBFB63C5Q33712962-65869298-EB8E-41A0-A79E-A56BE1DC5FB8Q33830395-70913FC0-5BB6-4545-8D9B-DE3E6A7043BBQ34016246-29D3B6DF-551B-4702-B557-26837F1FFA75Q34219925-C4405BB3-7149-4EA0-965D-84BFB7DC7343Q34345561-62541ED2-3643-4DD9-8A83-DD403A0346CCQ35071386-8AAA9113-DFF7-4D69-BD93-38BD41148908Q35088241-FD093CA4-0E4A-41D3-8B2C-22E896FF0944Q35597574-B3A71D65-55A3-4306-9156-959DF1802E2DQ36137542-965232D8-81AC-4A92-ABFC-5DD3174E6F1EQ36216050-1E1657B4-14AF-4BB8-B49D-F1DE87005ABAQ36298445-95BA4CC7-722B-4BFC-BEEA-79C6B0842EABQ36302442-21FD804A-D259-47CB-80BD-ED8D10634C98Q36647124-F3EF650A-A5F4-492F-AF8C-B187E5B78B91Q36992894-EFE53036-2F25-45E1-9B28-DF5A384A0D0BQ37112425-EC83084A-EB6B-4B2B-9325-401717EDD59CQ37355752-B537D261-D7BC-453A-9E2C-F794B533BA07Q37555374-FDA7F93E-32C4-4A1E-A019-6F37A6EE56B1Q37639779-43010145-8663-4CE4-BBEE-85FA93153DF0Q37722777-612DDEC1-44CA-4E52-9D30-8E99B9D56600Q37736345-60B6AA56-09E9-4859-876C-1E259D077E76Q39439883-2ABDE2DF-2F81-4A34-82B9-E2991FB7DFCEQ39462630-2996028C-E45A-4FCD-B201-5AEDBF5852D4Q39604148-B19C8D27-6A97-40F8-A06D-7E1B8D3B0C28Q40483810-A8AC415D-2796-4D65-81E8-69E7403DE48BQ40777639-40EF307E-F437-4EA6-9C30-0352B6FC8D68Q40850953-585E8AC9-6D39-4851-966B-0181BE542AEBQ40906092-7C31B200-4900-4A8E-B06F-F56371566E48Q41675000-F827B6CD-9708-47AF-BF73-91A1F49C0079Q41689291-8A4E013B-7E66-4747-98AB-A2C9BC80F6ECQ41718664-2E3A907A-9080-41C8-B605-B55B0B982C7CQ41846142-7F60C726-B43D-42CB-B476-AB673D14EA49Q41892375-740EF097-8570-45BD-863A-65BEDC74EF2BQ41892420-E563726C-E498-41D3-812B-B3E14EFB138AQ41919671-BC3D410E-B9A5-419E-B0AA-4E8ABB1088DFQ42197083-13B8F3EC-51E8-461F-B07B-DF46127D6D2EQ42244509-F16DD768-DDA1-4E92-B2E4-30491B9045B4
P50
name
Karin Klingel
@en
type
label
Karin Klingel
@en
prefLabel
Karin Klingel
@en